Overall, our findings shed novel light on the regulatory role of IGF2BP3-mediated MALAT1 nuclear-cytoplasmic shuttling and RNA stabilization via m6A modification during HCC progression. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.